<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0392439" disease_type="Disease or Syndrome" abbrv="">Acrodermatitis continua of Hallopeau</z:e> (ACH) is a rare manifestation of pustular <z:hpo ids='HP_0003765'>psoriasis</z:hpo> which may considerably disable affected patients </plain></SENT>
<SENT sid="1" pm="."><plain>In this case report we confirm the efficacy of <z:chebi fb="0" ids="50173">acitretin</z:chebi> in the treatment of ACH and, in addition, describe the course of the <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) from which the patient was suffering </plain></SENT>
<SENT sid="2" pm="."><plain>During <z:chebi fb="0" ids="50173">acitretin</z:chebi> treatment, there was a transformation into <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>We discuss the effect of <z:chebi fb="0" ids="26537">retinoids</z:chebi> on the bone marrow of <z:mpath ids='MPATH_458'>normal</z:mpath> subjects, patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Our experience in the present case, and the information from the available literature, lead us to advise against the use of the aromatic <z:chebi fb="0" ids="26537">retinoids</z:chebi>, <z:chebi fb="0" ids="50173">acitretin</z:chebi> and <z:chebi fb="0" ids="4913">etretinate</z:chebi>, in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>If such treatment is indicated, intensive haematological supervision is mandatory </plain></SENT>
</text></document>